Inogen, Inc.
NASDAQ:INGNMedical - Devices
Healthcare
$5.42 +0.71%
+$0.05 today
- Market cap
- $140.93M
- Beta
- 1.60
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.91
52W Low $5.34High $9.13
Volume 0.22M
Average 0.33M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$11.22M
FY 2025 · Annual
Investing Cash Flow
-$26.21M
FY 2025 · Annual
Financing Cash Flow
$24.18M
FY 2025 · Annual
+9025.3% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (6.33M) | (83.77M) | (102.45M) | (35.89M) | (22.75M) |
| Depreciation & Amortization | 21.63M | 23.51M | 18.15M | 21M | 20.66M |
| Deferred Income Tax | 14.44M | 0 | (251K) | (1.15M) | (1.1M) |
| Stock-Based Compensation | 10.94M | 12.28M | 7.43M | 7.4M | 8.01M |
| Change in Working Capital | (20.07M) | (44.72M) | 14.27M | (4.39M) | (26.91M) |
| Accounts Receivables | (5.42M) | (51.62M) | 11.13M | (5.07M) | (14.62M) |
| Inventory | (10.78M) | (5.6M) | 7.88M | (3.54M) | (3.21M) |
| Accounts Payables | (6.48M) | 6.76M | (9.18M) | (3.41M) | 5.6M |
| Other Working Capital | 2.61M | 5.74M | 4.44M | 7.63M | (14.68M) |
| Other Non-Cash Items | 3.02M | 55.16M | 59.62M | 18.94M | 10.87M |
| Operating Cash Flow | 23.63M | (37.53M) | (3.23M) | 5.91M | (11.22M) |
| Capital Expenditures | (23.94M) | (21.22M) | (26.52M) | (17.09M) | (10.38M) |
| Acquisitions (Net) | 153K | 331K | (29.44M) | 0 | 0 |
| Purchases of Investments | (9.99M) | 0 | (26.87M) | (32.66M) | (29.83M) |
| Sales of Investments | 19.26M | 10.01M | 24M | 35.5M | 14M |
| Other Investing Activities | 0 | 0 | 0 | (1.82M) | 0 |
| Investing Cash Flow | (14.65M) | (10.88M) | (59.32M) | (13.98M) | (26.21M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 15.65M | 1.74M | 1.48M | 811K | 28.18M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (647K) | (1.36M) | (518K) | (546K) | (4M) |
| Financing Cash Flow | 15M | 380K | 960K | 265K | 24.18M |
| Effect of Forex Changes | (426K) | (481K) | 67K | (281K) | 846K |
| Net Change in Cash | 23.56M | (48.51M) | (61.52M) | (8.08M) | (12.4M) |
| Free Cash Flow | (302K) | (58.75M) | (29.75M) | (11.18M) | (21.6M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$22.7M
+ D&A$20.7M
+ Stock-Based Comp$8.0M
- Deferred Tax-$1.1M
- Working Capital-$26.9M
+ Other Non-Cash$10.9M
= Operating Cash Flow-$11.2M
- Capex-$10.4M
= Free Cash Flow-$21.6M
Analysis
FY2025 free cash flow is -$21.6M. FCF conversion is 95.0% of net income. Operating cash flow was -$11.2M, with capex of -$10.4M. The largest bridge item is Working Capital at -$26.9M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Sep 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 3, 2026 |
Does INGN generate free cash flow?
Inogen, Inc. (INGN) generated -$21.60M of free cash flow in fiscal 2025.
How much operating cash flow does INGN produce?
Operating cash flow was -$11.22M, before capital expenditures of $10.38M.
Continue the stock analysis
Jump to another research area for this company.